Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2023
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer
Oladimeji Akinboro, Nicole Drezner, Anup Amatya, et al.
The Oncologist
|
February 14, 2018
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
The Oncologist
|
March 9, 2021
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, et al.
The Oncologist
|
December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2016
FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib
Erin Larkins, Gideon M Blumenthal, Huanyu Chen, et al.
Cancer Research Communications
|
March 2, 2023
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
Qi Liu, Chenan Zhang, Yue Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2021
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Erica C Nakajima, Paz J Vellanki, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Katie Chon, Erin Larkins, Somak Chatterjee, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 4, 2023
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer
Oladimeji Akinboro, Nicole Drezner, Anup Amatya, et al.
The Oncologist
|
February 14, 2018
FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring <i>BRAF V600E</i> Mutations
Lauretta Odogwu, Luckson Mathieu, Gideon Blumenthal, et al.
Journal of Neuro-Oncology
|
June 22, 2021
US Food and Drug Administration regulatory updates in neuro-oncology
Gautam U Mehta, Amy K Barone, Diana Bradford, et al.
The Oncologist
|
March 9, 2021
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, et al.
The Oncologist
|
December 16, 2017
FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B Goldberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2016
FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non-Small Cell Lung Cancer Following Crizotinib
Erin Larkins, Gideon M Blumenthal, Huanyu Chen, et al.
Cancer Research Communications
|
March 2, 2023
Evaluating Pneumonitis Incidence in Patients with Non-small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
Qi Liu, Chenan Zhang, Yue Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2021
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma
Erica C Nakajima, Paz J Vellanki, Erin Larkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 26, 2026
FDA Approval Summary: Tarlatamab for the Treatment of Extensive Stage Small Cell Lung Cancer
Yufan Liu, Jeannette Nashed, Amy K Barone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Katie Chon, Erin Larkins, Somak Chatterjee, et al.
Page
of 3